Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection

Transplant Proc. 2002 Aug;34(5):1610-1. doi: 10.1016/s0041-1345(02)03042-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Cyclosporine / pharmacokinetics
  • Cyclosporine / therapeutic use*
  • Daclizumab
  • Drug Therapy, Combination
  • Graft Rejection / prevention & control*
  • Graft Survival / drug effects
  • Graft Survival / immunology*
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use*
  • Sirolimus / pharmacokinetics
  • Sirolimus / therapeutic use*
  • Tacrolimus / pharmacokinetics
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Tissue Donors / statistics & numerical data

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Cyclosporine
  • Daclizumab
  • Mycophenolic Acid
  • Sirolimus
  • Tacrolimus